Finance

Beta
Lists
IOF:LON
Iofina plc
GBX 49.00
-1.01%
(-0.50) 1D
Jun 30, 4:46:59 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for IOF...
Open
GBX 49.00
High
GBX 51.00
Low
GBX 48.00
Mkt. cap
93.94M
Avg. vol.
539.19K
Volume
261.24K
P/E ratio
15.77
52-wk high
GBX 59.00
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
Open
GBX 49.00
High
GBX 51.00
Low
GBX 48.00
Mkt. cap
93.94M
Avg. vol.
539.19K
Volume
261.24K
P/E ratio
15.77
52-wk high
GBX 59.00
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
News stories
From sources across the web
Profile
Iofina plc is a US based vertically integrated company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. It markets around the globe via its business lines, Iofina Resources and Iofina Chemical. Iofina Resources is the group's iodine production business, which isolates iodine using its proprietary WET IOsorb technologies. It isolates iodine recovered from brine produced from oil and gas operations that would otherwise be wasted. It is the second-largest producer of iodine in North America, which currently imports the vast majority of its iodine. Iodine has numerous applications in human health, biocides, the manufacture of acetic, and many other areas. IR's iodine is either sold directly to global customers or converted to iodine-based compounds at its sister company, Iofina Chemical. Iofina Chemical is the group's halogen-based specialty chemical producer. IC has invested heavily in researching and developing new iodo-, chloro-, and fluoro-based specialty compounds and provides the global market with quality iodine products. Wikipedia
About Iofina plc
CEO-
Employees126
Founded2005
Headquarters-
SectorSpeciality chemicals
Websiteiofina.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
8.60%
8.60%
14.35%
14.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer